REGN News | REGN SEC Filings | REGN Buzz |
Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma Thursday April 25, 2024
EXEL vs. REGN: Which Stock Is the Better Value Option? Thursday April 25, 2024
Regeneron (REGN) Reports Next Week: What You Should Expect Thursday April 25, 2024
UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study Thursday April 25, 2024
The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power Thursday April 25, 2024
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth Thursday April 25, 2024
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases Thursday April 25, 2024
Regeneron expands in gene editing with Mammoth deal Thursday April 25, 2024
Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks Wednesday April 24, 2024
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO Wednesday April 24, 2024
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT) Monday April 22, 2024
Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock? Monday April 22, 2024
Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution Friday April 19, 2024
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success Thursday April 18, 2024
Why Investors Need to Take Advantage of These 2 Medical Stocks Now Wednesday April 17, 2024
Why Regeneron (REGN) Could Beat Earnings Estimates Again Tuesday April 16, 2024
UPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulation Monday April 15, 2024
Regeneron to defend against DOJ complaint on drug-price manipulation Monday April 15, 2024
Regeneron to defend US Justice Department's complaint on drug-pricing manipulation Monday April 15, 2024
Regeneron commits $500M to new venture capital fund Monday April 15, 2024